SurvivorNet on MSN
Could timing give your cancer treatment a boost? New study on the best time to receive immunotherapy & chemo for non-small cell lung cancer
A new randomized clinical trial showed that receiving immunochemotherapy infusions earlier in the day may help patients with ...
A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...
Each year, thousands of women diagnosed with breast cancer undergo surgery to remove tumors that cannot be felt by hand.
The ketogenic diet added to usual care may offer a small benefit for treatment-resistant depression, the authors concluded.
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...
Investigators based at Monash Children's Hospital and Royal Children's Hospital Melbourne report that a once-daily intranasal ...
Alvotech (NASDAQ:ALVO) reported positive findings from a pharmacokinetic trial evaluating AVT80, its experimental biosimilar to Entyvio, after the study successfully achieved all primary objectives.
A meta-analysis found that antibiotics in childhood were linked to a 42% higher risk for inflammatory bowel disease (IBD), ...
Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer Patients age 20 years and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results